These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 20678860)
1. Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status. Tian J; Peehl DM; Zheng W; Knox SJ Cancer Lett; 2010 Dec; 298(2):231-7. PubMed ID: 20678860 [TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of thiosemicarbazones with antifungal and antitumor effects: cellular iron chelation mediating cytotoxic activity. Opletalová V; Kalinowski DS; Vejsová M; Kunes J; Pour M; Jampílek J; Buchta V; Richardson DR Chem Res Toxicol; 2008 Sep; 21(9):1878-89. PubMed ID: 18698850 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy. Serda M; Kalinowski DS; Mrozek-Wilczkiewicz A; Musiol R; Szurko A; Ratuszna A; Pantarat N; Kovacevic Z; Merlot AM; Richardson DR; Polanski J Bioorg Med Chem Lett; 2012 Sep; 22(17):5527-31. PubMed ID: 22858101 [TBL] [Abstract][Full Text] [Related]
4. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311. Chaston TB; Lovejoy DB; Watts RN; Richardson DR Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494 [TBL] [Abstract][Full Text] [Related]
5. Novel thiosemicarbazones of the ApT and DpT series and their copper complexes: identification of pronounced redox activity and characterization of their antitumor activity. Jansson PJ; Sharpe PC; Bernhardt PV; Richardson DR J Med Chem; 2010 Aug; 53(15):5759-69. PubMed ID: 20597487 [TBL] [Abstract][Full Text] [Related]
6. 2-Acetylpyridine thiosemicarbazones are potent iron chelators and antiproliferative agents: redox activity, iron complexation and characterization of their antitumor activity. Richardson DR; Kalinowski DS; Richardson V; Sharpe PC; Lovejoy DB; Islam M; Bernhardt PV J Med Chem; 2009 Mar; 52(5):1459-70. PubMed ID: 19216562 [TBL] [Abstract][Full Text] [Related]
7. In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites. Potůčková E; Roh J; Macháček M; Sahni S; Stariat J; Šesták V; Jansová H; Hašková P; Jirkovská A; Vávrová K; Kovaříková P; Kalinowski DS; Richardson DR; Šimůnek T PLoS One; 2015; 10(10):e0139929. PubMed ID: 26460540 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agents. Kalinowski DS; Yu Y; Sharpe PC; Islam M; Liao YT; Lovejoy DB; Kumar N; Bernhardt PV; Richardson DR J Med Chem; 2007 Jul; 50(15):3716-29. PubMed ID: 17602603 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic action of merocyanine 540 on leukemia cells: iron-stimulated lipid peroxidation and cell killing. Lin F; Girotti AW Arch Biochem Biophys; 1993 Feb; 300(2):714-23. PubMed ID: 8434951 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and characterization of new iron chelators with anti-proliferative activity: structure-activity relationships of novel thiohydrazone analogues. Kalinowski DS; Sharpe PC; Bernhardt PV; Richardson DR J Med Chem; 2007 Nov; 50(24):6212-25. PubMed ID: 17963372 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway. Zhang AL; Russell PJ; Knittel T; Milross C Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933 [TBL] [Abstract][Full Text] [Related]
13. Anti-tumor activities of four chelating agents against human neuroblastoma cells. Shen L; Zhao HY; Du J; Wang F In Vivo; 2005; 19(1):233-6. PubMed ID: 15796180 [TBL] [Abstract][Full Text] [Related]
14. A series of alpha-heterocyclic carboxaldehyde thiosemicarbazones inhibit topoisomerase IIalpha catalytic activity. Huang H; Chen Q; Ku X; Meng L; Lin L; Wang X; Zhu C; Wang Y; Chen Z; Li M; Jiang H; Chen K; Ding J; Liu H J Med Chem; 2010 Apr; 53(8):3048-64. PubMed ID: 20353152 [TBL] [Abstract][Full Text] [Related]
15. Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors. Yu Y; Kalinowski DS; Kovacevic Z; Siafakas AR; Jansson PJ; Stefani C; Lovejoy DB; Sharpe PC; Bernhardt PV; Richardson DR J Med Chem; 2009 Sep; 52(17):5271-94. PubMed ID: 19601577 [No Abstract] [Full Text] [Related]
16. Synergism between cisplatin and radiotherapy in an in vitro prostate tumor cell line. Geldof AA; Kruit A; Newling DW; Slotman BJ Anticancer Res; 1999; 19(1A):505-8. PubMed ID: 10226589 [TBL] [Abstract][Full Text] [Related]
17. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Chendil D; Ranga RS; Meigooni D; Sathishkumar S; Ahmed MM Oncogene; 2004 Feb; 23(8):1599-607. PubMed ID: 14985701 [TBL] [Abstract][Full Text] [Related]
18. Oxygen- and temperature-dependent cytotoxic and radiosensitizing effects of cis-dichlorodiammineplatinum(II) on human NHIK 3025 cells in vitro. Melvik JE; Pettersen EO Radiat Res; 1988 Jun; 114(3):489-99. PubMed ID: 3375438 [TBL] [Abstract][Full Text] [Related]
19. Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells. Minelli A; Bellezza I; Tucci A; Rambotti MG; Conte C; Culig Z Prostate; 2009 Apr; 69(5):538-47. PubMed ID: 19107848 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]